Clinical trials
Phase 3 Gastrointestinal Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2005 | 1 |
| 2009 | 4 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Terminated | 6 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Bausch Health Americas, Inc. | 3 |
| Celgene | 3 |
| Ellodi Pharmaceuticals, LP | 3 |
| Pharmbio Korea Co., Ltd. | 3 |
| InDex Pharmaceuticals | 2 |
| National Center for Research Resources (NCRR) | 2 |
| Pfizer | 2 |
| Zealand Pharma | 2 |
| Abbott Nutrition | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Diseases | 45 |
| Digestive System Diseases | 22 |
| Intestinal Diseases | 18 |
| Colonic Diseases | 12 |
| Gastroenteritis | 11 |
| Rectal Diseases | 8 |
| Inflammatory Bowel Diseases | 7 |
| Colitis, Ulcerative | 6 |
| Esophageal Diseases | 6 |
| Gastrointestinal Neoplasms | 6 |
Trials
Showing 51 to 45 of 45. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.